Monitoring of drug treatment and psychosocial intervention with SPECT in Alzheimer patients: implications for neurologically appropriate psychosocial interventions. An observational study. The Osaki-Tajiri Project

Meguro, Kenichi; Kinomura, Shigeo; Sugamata, Kenji; Sato, Tachio; Kumai, Keiichi; Takada, Junko; Yamaguchi, Satoshi.
Dement. neuropsychol ; 12(4): 380-387, Oct.-Dec. 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-984330

Documentos relacionados

  1. Alzheimer's disease: From immunotherapy to immunoprevention.
  2. Accelerating Alzheimer's therapeutic development: The past and future of clinical trials.
  3. Monitoring of drug treatment and psychosocial intervention with SPECT in Alzheimer patients Implications for neurologically appropriate psychosocial interventions. An observational study. The Osaki-Tajiri Project.
  4. Breathing new life into the rational design of Alzheimer's therapeutics.
  5. [Aducanumab and Alzheimer's disease: a critical reflection.]
  6. Novel Pitolisant-Derived Sulfonyl Compounds for Alzheimer Disease.
  7. Effects of HSYA on serum and brain cholesterol levels in AD rats based on quantitative proteomics.
  8. Comparison of relative change with effect size metrics in Alzheimer's disease clinical trials.
  9. Multiomic prediction of therapeutic targets for human diseases associated with protein phase separation.
  10. Monoclonal antibodies for treating early Alzheimer disease-a commentary on recent 'positive' trials.